Clinical Trial Update: Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the efficacy and safety of Fluticasone furoate inhalation powder for asthma in adults and adolescents; the study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Arnuity Ellipta (Fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-08-08